INT2104 is a novel in vivo chimeric antigen receptor (CAR) gene therapy designed to generate CAR-T and CAR-NK cells in the patient’s body to target CD20-expressing malignant B cells Interim safety and ...
Disgraced movie mogul Harvey Weinstein is battling bone marrow cancer behind bars at Rikers Island in New York, according to reports.
ReSET-02 dose escalation Phase I is completedPhase II PoC randomized segment is startingNo dose-limiting toxicities, no safety or tolerability issuesThe highest dose is to be used in both ...
Alicia Zhou, PhD, became CRI’s president effective August 26, and succeeded Jill O’Donnell-Tormey, PhD, who had led the Institute since 1993.
"We are honored to welcome Alison to the Artiva Board of Directors. Her decades of executive experience in manufacturing and ...
New research demonstrates the potential of precise genome editing technologies, called adenine base editors, to correct disease-causing mutations in stem cells from patients with X-linked chronic ...
Olivia Newton-John is gone but her beloved daughter, Chloe Lattanzi, has been convinced the Grease legend is photo-bombing ...
The Blumberg Institute, a nonprofit biotechnology research and education organization focused on finding a cure for hepatitis ...
Favorable safety profile seen for relapsed/refractory large B-cell lymphoma patients monitored as outpatients or inpatients.
A Watertown biotech says is received a $112 million investment led by the investment firm that manages the assets of the Novo ...
ADRX-0405 is a novel antibody-drug conjugate targeting STEAP1, and a phase 1a/b study will investigate the agent for the ...
Breast cancer is the number one cancer among women: more than 2 million cases were diagnosed worldwide in 2022. It is also ...